DRUG
Price
$27.61
Change
-$0.20 (-0.72%)
Updated
Jun 6 closing price
Capitalization
195.2M
SEER
Price
$2.28
Change
+$0.10 (+4.59%)
Updated
Jun 6 closing price
Capitalization
128.28M
60 days until earnings call
Interact to see
Advertisement

DRUG vs SEER

Header iconDRUG vs SEER Comparison
Open Charts DRUG vs SEERBanner chart's image
Bright Minds Biosciences
Price$27.61
Change-$0.20 (-0.72%)
Volume$20K
Capitalization195.2M
Seer
Price$2.28
Change+$0.10 (+4.59%)
Volume$273.57K
Capitalization128.28M
DRUG vs SEER Comparison Chart
Loading...
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRUG vs. SEER commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRUG is a StrongBuy and SEER is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (DRUG: $27.35 vs. SEER: $1.99)
Brand notoriety: DRUG and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DRUG: 82% vs. SEER: 98%
Market capitalization -- DRUG: $195.2M vs. SEER: $128.28M
DRUG [@Biotechnology] is valued at $195.2M. SEER’s [@Biotechnology] market capitalization is $128.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRUG’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • DRUG’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, DRUG is a better buy in the long-term than SEER.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRUG’s TA Score shows that 5 TA indicator(s) are bullish while SEER’s TA Score has 4 bullish TA indicator(s).

  • DRUG’s TA Score: 5 bullish, 3 bearish.
  • SEER’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, DRUG is a better buy in the short-term than SEER.

Price Growth

DRUG (@Biotechnology) experienced а -10.12% price change this week, while SEER (@Biotechnology) price change was -4.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

SEER is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRUG($195M) has a higher market cap than SEER($128M). SEER YTD gains are higher at: -13.853 vs. DRUG (-24.070). DRUG has higher annual earnings (EBITDA): -2.67M vs. SEER (-93.93M). SEER has more cash in the bank: 236M vs. DRUG (57.9M). DRUG has less debt than SEER: DRUG (183K) vs SEER (26M). SEER has higher revenues than DRUG: SEER (13.9M) vs DRUG (0).
DRUGSEERDRUG / SEER
Capitalization195M128M152%
EBITDA-2.67M-93.93M3%
Gain YTD-24.070-13.853174%
P/E RatioN/AN/A-
Revenue013.9M-
Total Cash57.9M236M25%
Total Debt183K26M1%
TECHNICAL ANALYSIS
Technical Analysis
DRUGSEER
RSI
ODDS (%)
Bullish Trend 12 days ago
69%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
87%
Bullish Trend 12 days ago
85%
Momentum
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
84%
MACD
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
71%
Advances
ODDS (%)
Bullish Trend 24 days ago
85%
Bullish Trend 26 days ago
75%
Declines
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 24 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
81%
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
DRUG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

DRUG and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRUG has been loosely correlated with PHMMF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if DRUG jumps, then PHMMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRUG
1D Price
Change %
DRUG100%
-0.33%
PHMMF - DRUG
44%
Loosely correlated
N/A
TVGN - DRUG
31%
Poorly correlated
+1.55%
ATYR - DRUG
31%
Poorly correlated
+8.53%
SEER - DRUG
29%
Poorly correlated
+1.53%
PHGUF - DRUG
28%
Poorly correlated
N/A
More

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with PALI. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then PALI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
+1.53%
PALI - SEER
38%
Loosely correlated
-5.47%
DNLI - SEER
38%
Loosely correlated
-1.29%
RGNX - SEER
36%
Loosely correlated
-5.84%
ARWR - SEER
35%
Loosely correlated
+1.24%
NUVB - SEER
34%
Loosely correlated
-1.79%
More